Français
ItalianoBond AstraZeneca 5.9% ( US046353AB45 ) in USD
| Issuer | AstraZeneca | ||||||||
| Market price | 100 % ⇌ | ||||||||
| Country |  United Kingdom
|
||||||||
| ISIN code |
 US046353AB45 ( in USD )
|
||||||||
| Interest rate | 5.9% per year ( payment 2 times a year) | ||||||||
| Maturity | 09/15/2017 - Bond has expired | ||||||||
| Minimal amount | 1 000 USD | ||||||||
| Total amount | 1 750 000 000 USD | ||||||||
| Cusip | 046353AB4 | ||||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||||
| Detailed description |
AstraZeneca is a British-Swedish multinational pharmaceutical and biopharmaceutical company that discovers, develops, manufactures, and markets prescription drugs globally. The Bond issued by AstraZeneca ( United Kingdom ) , in USD, with the ISIN code US046353AB45, pays a coupon of 5.9% per year. The coupons are paid 2 times per year and the Bond maturity is 09/15/2017 The Bond issued by AstraZeneca ( United Kingdom ) , in USD, with the ISIN code US046353AB45, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AstraZeneca ( United Kingdom ) , in USD, with the ISIN code US046353AB45, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||